ePrescribing: DEA-EPCS Digital Certificates
ADL Data Systems is excited to announce our Order Entry application is now DEA Certified for EPCS (ePrescribing of Controlled Substances)
The EPCS feature eliminates the need to print controlled substance prescriptions simplifying the process for physicians, nurses and pharmacists. ePrescribing DEA drugs eliminates the possible misuse of printed prescriptions.
The feature enforces 2-factor authentication for prescription of narcotic drugs to ensure that drugs are not prescribed by unauthorized employees like medical assistants, nurses, or administrative staff.
ADL has partnered with IdenTrust to provide identity proofing and issuance of Digital Certificate Tokens used to digitally sign and electronically send prescriptions for controlled substances. By providing the required information to IdenTrust, you will have complete remote identity proofing that will be valid for two years.
To complete your identity proofing you will need to provide your name, address, phone number, date of birth, Social Security number, a credit card number and your driver’s license to IdenTrust. This process will take approximately one week. Once you have received your digital certificate and installed it, register it on the ADL Data DEA-EPCS sign up screen to begin electronically sending controlled substances prescriptions.
ADL’s ePrescribing system has been certified by iBeta.
- Transmittal Letter – Certification Report Addendum
- DEA EPCS Certification Report Addendum for ADL Prescriber Application 2016
The Drug Enforcement Administration (DEA) has approved iBeta’s Certification Process for a Biometrics Subsystem for the Electronic Prescriptions for Controlled Substances (EPCS) pursuant to 21 Code of Federal Regulations (C.F.R) § 1311.300. This announcement can be found on the federal Registry site at https://www.federalregister.gov/articles/2012/08/01/2012-18748/electronic-prescriptions-for-controlled-substances-notice-of-approved-certification-process.
iBeta is now authorized to review, verify and certify that particular electronic prescribers or electronic pharmacy applications meet the requirements of DEA’s regulations governing EPCS. iBeta’s EPCS device authorization is limited to the biometric subsystem.
The DEA-EPCS program allows practitioners, hospitals and pharmacies the option to utilize electronic prescriptions for controlled substances. The Interim Final Rule (March 31, 2010) allows that a biometric can serve as one factor in the two-factor authentication. The three possible factors for authentication recognized by the DEA are: something you know, something you have and something you are (such as a biometric).
Please contact us @ 914-591-1800 if you would like more information.